🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseHas anyone dealt with had a fibroscan and do not understand my results - help? Page 4

Has anyone dealt with had a fibroscan and do not understand my results - help?

pat_auckland Fri, Apr 5, 2024 at 7:32 AM 42 replies 2,471 viewsPage 4 of 9
Dr.DermMIA
Member
456
2,123
May 2024
Miami, FL
Apr 6, 2024 at 6:04 AM#16

Clinical perspective, offered as context rather than as advice. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

Last edited: Apr 6, 2024 at 8:04 AM
30 3LipidDoc_ATL, BariatricNurseD, MASHdoc_SA and 27 others
Reply Quote Save Share Report
tane_welly
Member
234
1,123
Sep 2024
Wellington, NZ
Apr 6, 2024 at 8:47 AM#17
Dr.DermMIA said:
If two explanations both fit, the useful question is which one predicts something the other does not.

I read this differently from Dr.DermMIA, on substance rather than tone. Pushing back on the consensus forming here. Consistency is not the same as correctness, and a board that agrees with itself quickly is usually agreeing with the first person who sounded certain.

31 4carl_compliance, DanielChem_CHI, marco_milano and 28 others
Reply Quote Save Share Report
GenomicsKate
Member
345
1,890
Oct 2024
Cambridge, MA
Apr 6, 2024 at 11:30 AM#18
Dr.DermMIA said:
If two explanations both fit, the useful question is which one predicts something the other does not.

Agreed, and the size of the effect matters as much as its existence. Something real and small gets treated here as though it were real and decisive.

32 5MarkLI_maint, Dr.PeteFamMed, claudia_zurich and 29 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
MikeNYC_runner
Member
378
1,678
Jul 2024
New York, NY
Apr 6, 2024 at 2:13 PM#19
Dr.DermMIA said:
If two explanations both fit, the useful question is which one predicts something the other does not.

Thank you — that is the clearest version of this I have read, and I have read a lot of them.

33 6GenomicsKate, Dr.ObesityMed, HealthEcon_DC and 30 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Apr 6, 2024 at 4:56 PM#20

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. Thread quality here is what the rules are for. Keep it up.

5 3PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 2 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register